Article
Massive Clonal Selection and Transiently Contributing Clones During Expansion of Mesenchymal Stem Cell Cultures Revealed by Lentiviral RGB-Barcode Technology.
Stem cells translational medicine - 1 May 2016
Selich Anton, Daudert Jannik, Hass Ralf, Philipp Friederike, von Kaisenberg Constantin, Paul Gabi, Cornils Kerstin, Fehse Boris, Rittinghausen Susanne, Schambach Axel, Rothe Michael
Abstract excerpt
UNLABELLED: Mesenchymal stem (or stromal) cells (MSCs) have been used in more than 400 clinical trials for the treatment of various diseases. The clinical benefit and reproducibility of results, however, remain extremely variable. During the in vitro expansion phase, which is necessary to achieve clinically relevant cell numbers, MSCs show signs of aging accompanied by different contributions of single clones to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
